ES8301982A1 - Procedimiento para la isomerizacion de derivados de ergolina - Google Patents

Procedimiento para la isomerizacion de derivados de ergolina

Info

Publication number
ES8301982A1
ES8301982A1 ES505669A ES505669A ES8301982A1 ES 8301982 A1 ES8301982 A1 ES 8301982A1 ES 505669 A ES505669 A ES 505669A ES 505669 A ES505669 A ES 505669A ES 8301982 A1 ES8301982 A1 ES 8301982A1
Authority
ES
Spain
Prior art keywords
ergoline
ergoline derivatives
anion
isomerisation process
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES505669A
Other languages
English (en)
Other versions
ES505669A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz AG filed Critical Sandoz AG
Publication of ES8301982A1 publication Critical patent/ES8301982A1/es
Publication of ES505669A0 publication Critical patent/ES505669A0/es
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D457/00Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
    • C07D457/02Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with hydrocarbon or substituted hydrocarbon radicals, attached in position 8
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D457/00Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
    • C07D457/04Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 8
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D457/00Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
    • C07D457/04Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 8
    • C07D457/06Lysergic acid amides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D457/00Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
    • C07D457/10Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with hetero atoms directly attached in position 8
    • C07D457/12Nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

PROCEDIMIENTO PARA LA ISOMERIZACION DE DERIVADOS DE ERGOLINA, EN PARTICULAR PARA LA OBTENCION DE ERGOLINAS SUSTITUIDAS EN POSICION <007>. CONSISTE EN LA FORMACION DE UN ANION DE UNA ERGOLINA SUSTITUIDA EN POSICION 8<021> POR UN GRUPO CAPTADOR DE ELECTRONES, MEDIANTE LA ELIMINACION DE UN PROTON SITUADO EN LA POSICION 8<007>, A TRAVES DE LA ACCION DE UNA BASE FUERTE BAJO LAS CONDICIONES DE LA REACCION, NO NUCLEOFILA; SEGUIDA DE LA PROTONACION DEL ANION OBTENIDO. ESTOS COMPUESTOS TIENEN APLICACIONES FARMACOLOGICAS POR SUS PROPIEDADES DOPOMINERGICAS.
ES505669A 1980-09-23 1981-09-21 Procedimiento para la isomerizacion de derivados de ergolina Granted ES505669A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH712280A CH644606A5 (de) 1980-09-23 1980-09-23 Verfahren zur isomerisierung von 9,10-dihydrolysergsaeurederivaten.

Publications (2)

Publication Number Publication Date
ES8301982A1 true ES8301982A1 (es) 1982-12-16
ES505669A0 ES505669A0 (es) 1982-12-16

Family

ID=4320306

Family Applications (1)

Application Number Title Priority Date Filing Date
ES505669A Granted ES505669A0 (es) 1980-09-23 1981-09-21 Procedimiento para la isomerizacion de derivados de ergolina

Country Status (27)

Country Link
US (1) US4515950A (es)
EP (1) EP0048695B1 (es)
JP (1) JPS5785385A (es)
KR (1) KR870001508B1 (es)
AT (1) ATE7916T1 (es)
AU (1) AU547647B2 (es)
CA (1) CA1178581A (es)
CH (1) CH644606A5 (es)
CS (1) CS228518B2 (es)
DD (1) DD201679A5 (es)
DE (1) DE3164195D1 (es)
DK (1) DK418781A (es)
ES (1) ES505669A0 (es)
FI (1) FI70018C (es)
GR (1) GR75044B (es)
HU (1) HU185317B (es)
IE (1) IE51593B1 (es)
IL (1) IL63902A (es)
MA (1) MA19281A1 (es)
NO (1) NO155967C (es)
NZ (1) NZ198436A (es)
PH (1) PH19436A (es)
PL (1) PL134179B1 (es)
PT (1) PT73713B (es)
SU (1) SU1152521A3 (es)
YU (1) YU42426B (es)
ZA (1) ZA816617B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3309493A1 (de) * 1983-03-14 1984-09-20 Schering AG, 1000 Berlin und 4709 Bergkamen Neue ergolin-derivate, verfahren zu ihrer herstellung sowie verwendung als arzneimittel
CH664568A5 (de) * 1984-01-12 1988-03-15 Sandoz Ag 8-alpha-acylaminoergoline.
DE3533675A1 (de) * 1985-09-19 1987-03-26 Schering Ag Neue 12- und 13-brom-ergolinderivate
DE3533672A1 (de) * 1985-09-19 1987-03-26 Schering Ag Neue 12- und 13-substituierte ergolinderivate
DE3708028A1 (de) * 1987-03-10 1988-09-22 Schering Ag Verfahren zur herstellung von 2,3ss-dihydroergolinen, 2-substituierte 2,3ss-dihydroergoline und ihre verwendung als arzneimittel
BR112017015510A2 (pt) 2015-01-20 2018-01-30 Xoc Pharmaceuticals Inc composto de fórmula estrutural (i), método de tratamento e/ou prevenção, método de agonização do receptor d2 em um indivíduo, método de antagonização do receptor d3 em um indivíduo, método de agonização do receptor 5-ht1d em um indivíduo, método de agonização do receptor 5-ht1a em um indivíduo, método de agonização seletiva do receptor 5-ht1d em vez do receptor 5-ht1b em um indivíduo, método de agonização seletiva do re-ceptor 5-ht2c em vez do receptor 5-ht2a ou 5-ht2b em um indivíduo, método de agonização do receptor 5-ht2c em um indivíduo, método de fornecimento de atividade antagonista funcional no receptor 5-ht2b ou receptor 5-ht7, e, método de fornecimento de atividade antagonista funcional nos receptores adrenérgicos em um indivíduo
CN113149982A (zh) 2015-01-20 2021-07-23 Xoc制药股份有限公司 麦角灵化合物及其用途
JP2020522504A (ja) 2017-06-01 2020-07-30 エックスオーシー ファーマシューティカルズ インコーポレイテッドXoc Pharmaceuticals, Inc 多環式化合物およびそれらの用途

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3817988A (en) * 1971-11-16 1974-06-18 Res Inst Medicine Chem PROCESS FOR 11,12-ENOLISATION OF 9a-HALO-11-KETO-STEROIDS
CH585750A5 (en) * 1973-10-12 1977-03-15 Sandoz Ag Prepn. of (8)-methyl-dihydro-lysergic acid derivs. - from (7)-ergolene-(8)-carboxylates by methylation and redn.
GB1517971A (en) * 1974-07-19 1978-07-19 Sandoz Ltd 8alpha-substituted ergoline i derivatives
US3968111A (en) * 1974-12-06 1976-07-06 Eli Lilly And Company 8,8-Disubstituted-6-methylergolines and related compounds
DE2656344A1 (de) * 1975-12-23 1977-07-07 Sandoz Ag Ergolinderivate, ihre verwendung und herstellung
DE3063869D1 (en) * 1979-06-13 1983-07-28 Schering Ag (ergolin-yl)-n', n'-diethyl urea derivatives, their preparation and pharmaceutical compositions containing them
US4246265A (en) * 1979-10-01 1981-01-20 Eli Lilly And Company 6-n-Propyl-8α-methoxymethyl or methylmercaptomethylergolines and related compounds
DE3001752A1 (de) * 1980-01-16 1981-07-30 Schering Ag Berlin Und Bergkamen, 1000 Berlin Verfahren zur herstellung von 8(alpha)-substituierten 6-methylergolinen

Also Published As

Publication number Publication date
AU547647B2 (en) 1985-10-31
JPS5785385A (en) 1982-05-28
FI70018C (fi) 1986-09-12
AU7555681A (en) 1982-04-01
IE812201L (en) 1982-03-23
PL233129A1 (es) 1982-05-10
NO813196L (no) 1982-03-24
MA19281A1 (fr) 1982-04-01
EP0048695A1 (de) 1982-03-31
SU1152521A3 (en) 1985-04-23
PL134179B1 (en) 1985-07-31
DK418781A (da) 1982-03-24
PH19436A (en) 1986-04-15
IL63902A0 (en) 1981-12-31
GR75044B (es) 1984-07-12
NO155967B (no) 1987-03-23
KR830007641A (ko) 1983-11-04
PT73713B (en) 1983-05-11
CS228518B2 (en) 1984-05-14
IL63902A (en) 1986-07-31
US4515950A (en) 1985-05-07
ES505669A0 (es) 1982-12-16
CH644606A5 (de) 1984-08-15
KR870001508B1 (ko) 1987-08-20
ZA816617B (en) 1983-04-27
ATE7916T1 (de) 1984-06-15
NO155967C (no) 1987-07-01
FI70018B (fi) 1986-01-31
YU227581A (en) 1983-10-31
DD201679A5 (de) 1983-08-03
IE51593B1 (en) 1987-01-21
NZ198436A (en) 1985-07-12
CA1178581A (en) 1984-11-27
EP0048695B1 (de) 1984-06-13
HU185317B (en) 1985-01-28
DE3164195D1 (en) 1984-07-19
FI812894L (fi) 1982-03-24
YU42426B (en) 1988-08-31
PT73713A (en) 1981-10-01

Similar Documents

Publication Publication Date Title
NL7703969A (nl) Werkwijze ter bereiding van syn-isomeren van 3,7-di-gesubstitueerde 3-cefem-4-carbonzuur- verbindingen.
NL159007B (nl) Werkwijze ter bereiding van een emulsie van een zuurstofoverdragende, verzadigde perfluorkoolstofverbinding.
MX9404778A (es) Preparacion electroquimica de catalizadores para polimerizacion poradicion.
BE838754A (fr) Procede ameliore pour la preparation de dimethylol-2, 2-alcanals
ES448220A1 (es) Un procedimiento para preparar un compuesto cristalino 6 al-fa, fluoro-11 beta, 21-hihidroxi-16 alfa, 17alfa-zsopropili-dendioxipregna-1,4-dien-3,20-diona.
FR2301503A1 (fr) Procede de preparation de 1 alpha, 25-dihydroxycholecalciferol
FR2313357A1 (fr) Procede de preparation du 1,4-diaminoanthraquinone-2,3-dinitrile
ES428005A1 (es) Procedimiento para la preparacion de derivados de 3-4-dihi-dro-2h-naftalenom-(1)-5-oxi-propil-piperazina.
FR2278692A2 (fr) Procede de preparation du sel de potassium de la 2,2-dioxo-6-methyl-3,4-dihydro-1,2,3-oxathiazine-4-one
MA19281A1 (fr) Procede d&#39;isomerisation de derives de l&#39;ergoline .
AR209485A1 (es) Procedimiento para la fabricacion de 3,5 -dialquil -4- hidroxibenzaldehido por formilacion del correspondiente 2,6-dialquilfenol
BE844259A (fr) Procede de preparation d&#39;aldehydes &amp;,b-ethyleniques
BE758078A (fr) Procede de preparation d&#39;homopolymeres d&#39;halogenures de vinyle ayant des caracteristiques ameliorees de mise en oeuvre
NL7608139A (nl) Werkwijze ter bereiding van 2-chloorbutadieen- -1,3.
BE814249A (fr) Procede de preparation de phtalazino (2,3-b)
BE849640A (fr) Procede de preparation de 1,1-dihalogeno-4-methyl-1,3-pentadienes
BE844739A (fr) Procede de preparation de cyclohexane-diones-1,3
ES2056198T3 (es) Procedimiento para la preparacion de poliglicidil-eteres.
BE843910A (fr) Procede de preparation de 2,5-dioxo-1-oxa-2-phospholanes
BE842223A (fr) Procede de preparation du 1,5- et du 1,8-diaminonaphtalene
FR2342270A1 (fr) Procede de preparation de 1,2-cycloalcanediones par auto-oxydation de cycloalcanones
BE840837A (fr) Procede de preparation de la 1,8-dinitro-anthraquinone pure
BE829352A (fr) Procede de preparation de bis- alpha alpha alpha trisarylmethl) 1,3 ou -1,4 benzenes
BE819943A (fr) Procede de preparation de nouvelles 3,4-dihydro-1,2,4-triazines
BE846574A (fr) Procede de preparation de maleate hydrogene de t-butylamino-3-(4-morpholino-1,2,5-thiadiazole-3-yloxy)-2-propanol utilise en ophtalmologie